BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 27283073)

  • 1. Detecting Pulmonary Nodules in Lung Cancer Patients Using Whole Body FDG PET/CT, High-resolution Lung Reformat of FDG PET/CT, or Diagnostic Breath Hold Chest CT.
    Flavell RR; Behr SC; Mabray MC; Hernandez-Pampaloni M; Naeger DM
    Acad Radiol; 2016 Sep; 23(9):1123-9. PubMed ID: 27283073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary nodule detection in oncological patients - Value of respiratory-triggered, periodically rotated overlapping parallel T2-weighted imaging evaluated with PET/CT-MR.
    de Galiza Barbosa F; Geismar JH; Delso G; Messerli M; Huellner M; Stolzmann P; Veit-Haibach P
    Eur J Radiol; 2018 Jan; 98():165-170. PubMed ID: 29279157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.
    Schwyzer M; Martini K; Benz DC; Burger IA; Ferraro DA; Kudura K; Treyer V; von Schulthess GK; Kaufmann PA; Huellner MW; Messerli M
    Eur Radiol; 2020 Apr; 30(4):2031-2040. PubMed ID: 31822970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of FDG PET/CT for Preoperative Staging of Non-Small Cell Lung Cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller.
    Suh YJ; Park CM; Han K; Jeon SK; Kim H; Hwang EJ; Lee JH; Paeng JC; Lee CH; Kim YT; Goo JM
    AJR Am J Roentgenol; 2020 Mar; 214(3):514-523. PubMed ID: 31846374
    [No Abstract]   [Full Text] [Related]  

  • 7. Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer.
    Allen-Auerbach M; Yeom K; Park J; Phelps M; Czernin J
    J Nucl Med; 2006 Feb; 47(2):298-301. PubMed ID: 16455636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Jan; 57(1):15-20. PubMed ID: 26514173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Cervino AR; Vinante L; Al-Nahhas A; Rubello D; Muzzio PC; Polverosi R
    J Med Imaging Radiat Oncol; 2012 Aug; 56(4):417-24. PubMed ID: 22883649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.
    Stolzmann P; Veit-Haibach P; Chuck N; Rossi C; Frauenfelder T; Alkadhi H; von Schulthess G; Boss A
    Invest Radiol; 2013 May; 48(5):241-6. PubMed ID: 23070096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
    Hadique S; Jain P; Hadi Y; Baig A; Parker JE
    BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
    Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
    Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the optimal acquisition protocol of breath-hold PET/CT for the diagnosis of thoracic lesions.
    Mitsumoto K; Abe K; Sakaguchi Y; Zhang T; Tachiya Y; Ohya N; Baba S; Sasaki M
    Nucl Med Commun; 2011 Dec; 32(12):1148-54. PubMed ID: 21968434
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
    O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
    J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy.
    Koslow M; Young JR; Yi ES; Baqir M; Decker PA; Johnson GB; Ryu JH
    Eur Radiol; 2019 Apr; 29(4):1684-1692. PubMed ID: 30288558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.